Bone mineral density in children and adolescents with perinatal HIV infection

No abstract is available for this paper.

• Publication year

  2013

• Venue

  AIDS (London)

• Publication date

  2013-01-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/QAD.0b013e32835a9b80PMID 23032412PMCID PMC4157938
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 Pediatric Official Positions.

  2014cited by this paper
• Fracture risk by HIV infection status in perinatally HIV-exposed children.

  2012cited by this paper
• Healthcare Systems

  2012cited by this paper
• Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study

  2012cited by this paper
• Increased Risk of Fragility Fractures among HIV Infected Compared to Uninfected Male Veterans

  2011cited by this paper
• Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort Study.

  2011cited by this paper
• Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006.

  2011cited by this paper
• The impact of different types of physical activity on total and regional bone mineral density in young Brazilian athletes

  2011cited by this paper
• Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats

  2010cited by this paper
• Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women.

  2010cited by this paper
• Bone disease in HIV infection: a practical review and recommendations for HIV care providers.

  2010cited by this paper
• Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045

  2010cited by this paper
• Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection.

  2010cited by this paper
• Continuous antiretroviral therapy decreases bone mineral density

  2009cited by this paper
• First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir

  2009influential reference
• Bone loss in patients with HIV infection.

  2009cited by this paper
• Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2007 Pediatric Official Positions.

  2008cited by this paper
• HIV‐1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFα activation

  2008cited by this paper
• Decreased bone mineral density with off-label use of tenofovir in children and adolescents infected with human immunodeficiency virus.

  2008cited by this paper
• Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system.

  2008cited by this paper
• CLINICAL Review # : low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis.

  2007cited by this paper
• Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study

  2007cited by this paper
• Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review

  2006influential reference
• Peak bone mass

  2005cited by this paper
• Interactions among human immunodeficiency virus (HIV)‐1, interferon‐γ and receptor of activated NF‐κ B ligand (RANKL): implications for HIV pathogenesis

  2004cited by this paper
• Interactions among human immunodeficiency virus (HIV)-1, interferon-gamma and receptor of activated NF-kappa B ligand (RANKL): implications for HIV pathogenesis.

  2004cited by this paper
• Difference in bone mass between black and white American children: attributable to body build, sex hormone levels, or bone turnover?

  2003cited by this paper
• Altered bone metabolism in children infected with human immunodeficiency virus

  2003cited by this paper
• Select HIV Protease Inhibitors Alter Bone and Fat Metabolismex Vivo *

  2002cited by this paper
• Body composition changes in protease inhibitor‐naive HIV‐infected patients treated with two nucleoside reverse transcriptase inhibitors

  2002influential reference
• Peak Bone Mass

  2000cited by this paper
• Peak bone mineral accrual and age at menarche in adolescent girls: a 6-year longitudinal study.

  1998cited by this paper
• Bone “mass” and the “mechanostat”: A proposal

  1987cited by this paper
• Radiographic Atlas of Skeletal Development of the Hand and Wrist

  1950cited by this paper

• Longitudinal changes in bone mineral density among children living with HIV over 96 weeks following switch to second-line antiretroviral therapy in Uganda.

  2026cites this paper
• Bone health in a U.K. cohort of youth living with perinatally acquired HIV‐1: a longitudinal study

  2025cites this paper
• Reduced bone density accrual among peripubertal boys with HIV in Zimbabwe

  2025cites this paper
• Comparison between dual energy X-ray absorptiometry and calcaneal quantitative ultrasound for determining bone mineral density in children living with HIV in uganda: A cross- sectional study

  2025cites this paper
• Longitudinal Evaluation of Bone Safety in Children and Adolescents With HIV-1 Starting Tenofovir Alafenamide-Containing Antiretroviral Therapy

  2025cites this paper
• Health-Related Physical Fitness Evaluation in HIV-Diagnosed Children and Adolescents: A Scoping Review

  2024cites this paper
• Adults with Perinatally Acquired HIV; Emerging Clinical Outcomes and Data Gaps

  2024cites this paper
• Bone Accrual Trajectories in Children and Adolescents with Perinatal HIV Infection.

  2024cites this paper
• A Three-Year Follow-Up of Bone Density Among Thai Adolescents With Perinatally Acquired HIV After Completion of Vitamin D and Calcium Supplementation.

  2023cites this paper
• Bone mineral density among children living with HIV failing first-line anti-retroviral therapy in Uganda: A sub-study of the CHAPAS-4 trial

  2023cites this paper
• Bone Mineral Content Prediction by Bioelectrical Impedance Analysis in Children and Adolescents Diagnosed with HIV Infection: Comparison with Dual Energy X-ray Absorptiometry: A Cross-Sectional Study

  2022cites this paper
• A Systematic Review and Meta-Analysis of Randomized Controlled Trials of the Effects of Vitamin D Supplementation on Children and Young Adults with HIV Infection.

  2022cites this paper
• Official Position of the Brazilian Association of Bone Assessment and Metabolism (ABRASSO) on the evaluation of body composition by densitometry—part II (clinical aspects): interpretation, reporting, and special situations

  2022cites this paper
• Effect of HIV infection on growth and bone density in peripubertal children in the era of antiretroviral therapy: a cross-sectional study in Zimbabwe

  2021cites this paper
• The perceived challenges of perinatal HIV in adolescents: a qualitative study

  2021cites this paper
• Correlation between mandibular bone density, CD4 T-cells, and duration of HAART in HIV-infected children

  2021cites this paper
• Bone outcomes in virally suppressed youth with HIV switching to tenofovir disoproxil fumarate

  2021cites this paper
• Impact of vitamin D and calcium supplementation on bone mineral density and bone metabolism among Thai adolescents with perinatally acquired HIV infection: A randomized clinical trial.

  2021cites this paper
• Height adjustment reduces occurrence of low bone mineral density in children and adolescents with HIV.

  2021cites this paper
• Timing, Dosage, and Adherence of Antiretroviral Therapy and Risk of Osteoporosis in Patients With Human Immunodeficiency Virus Infection in Taiwan: A Nested Case-Control Study

  2021cites this paper
• Bisphosphonates in Perinatally Infected Children and Adolescents with HIV; Targeting Puberty.

  2020cites this paper
• Deficits in bone architecture and strength in children living with HIV on antiretroviral therapy.

  2020cites this paper
• Patterns of Objectively and Self-Reported Sedentary Behavior in Children and Adolescents Living With Human Immunodeficiency Virus: The PositHIVe Health Study.

  2020cites this paper
• Prevalence and predictors of bone health among perinatally HIV-infected adolescents.

  2020cites this paper
• Fractures in children and adolescents living with perinatally acquired HIV.

  2020cites this paper
• Safety and efficacy of 48 and 96 weeks of alendronate in children and adolescents with perinatal HIV infection and low bone mineral density for age.

  2020cites this paper
• Adolescents and young adults with early acquired HIV infection in the united states: unique challenges in treatment and secondary prevention

  2020cites this paper
• The IMpact of Vertical HIV infection on child and Adolescent SKeletal development in Harare, Zimbabwe (IMVASK Study): a protocol for a prospective cohort study

  2020cites this paper
• Alendronate improves bone mineral density in perinatally HIV-infected children and adolescents with low bone mineral density for age.

  2019cites this paper
• Impact of HIV-1 Infection and Antiretroviral Therapy on Bone Homeostasis and Mineral Density in Vertically Infected Patients

  2019cites this paper
• Markers of Bone Mineral Metabolism and Cardiac Structure and Function in Perinatally HIV-Infected and HIV-Exposed but Uninfected Children and Adolescents

  2019cites this paper
• Tenofovir Has Minimal Effect on Biomarkers of Bone Health in Youth with HIV Receiving Initial Antiretroviral Therapy

  2019cites this paper
• Bone Quality Measured Using Calcaneal Quantitative Ultrasonography Is Reduced Among Children with HIV in Johannesburg, South Africa.

  2019cites this paper
• [Evaluation of bone mineral density in children with vertical infection by HIV].

  2018cites this paper
• Effect of calcium and vitamin D supplementation on bone mineral accrual among HIV-infected Thai adolescents with low bone mineral density

  2018cites this paper
• The impact of vitamin D supplementation on musculoskeletal health outcomes in children, adolescents, and young adults living with HIV: A systematic review

  2018cites this paper
• Effects of cholecalciferol supplementation on serum and urinary vitamin D metabolites and binding protein in HIV-infected youth.

  2017cites this paper
• The Association of Fat and Lean Tissue With Whole Body and Spine Bone Mineral Density Is Modified by HIV Status and Sex in Children and Youth

  2017cites this paper
• Safety, efficacy, and pharmacokinetics of single-tablet elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed, HIV-infected children: a single-arm, open-label trial.

  2017cites this paper
• Adverse bone health and abnormal bone turnover among perinatally HIV‐infected Asian adolescents with virological suppression

  2017cites this paper
• Effects of Vitamin D Supplementation on Bone Mineral Density and Bone Markers in HIV-Infected Youth

  2017cites this paper
• Aerobic Fitness and Moderate to Vigorous Physical Activity in Children and Adolescents Living with HIV.

  2017cites this paper
• Effect of Antiretroviral Therapy on Bone and Renal Health in Young Adults Infected With HIV in Early Life

  2017cites this paper
• It is Time to Explore the Potential Benefit of Routine Micronutrient Supplementation in Optimizing Bone Health and Growth in HIV Exposed Uninfected Children in the Context of Early Antiretroviral Exposure in Resource Limited Settings

  2017cites this paper
• Associations of Low Vitamin D and Elevated Parathyroid Hormone Concentrations With Bone Mineral Density in Perinatally HIV-Infected Children

  2017cites this paper
• Low Bone Mineral Density in Vertically HIV-infected Children and Adolescents: Risk Factors and the Role of T-cell Activation and Senescence

  2017cites this paper
• Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception

  2017cites this paper
• Following young people with perinatal HIV infection from adolescence into adulthood: the protocol for PHACS AMP Up, a prospective cohort study

  2016cites this paper
• Effect of high-dose cholecalciferol (vitamin D3) on bone and body composition in children and young adults with HIV infection: a randomized, double-blind, placebo-controlled trial

  2016cites this paper
• HIV-AIDS and Aging: Challenges and Management

  2016cites this paper
• HIV Exposed Uninfected Children at School Age: Developing Country Context

  2016cites this paper
• Final Height and Associated Factors in Perinatally HIV-infected Asian Adolescents

  2016cites this paper
• Efavirenz is associated with higher bone mass in South African children with HIV

  2016cites this paper
• Bone health in HIV-infected children and adolescents

  2016cites this paper
• Increased Immune Activation and Exhaustion in HIV-infected Youth

  2016cites this paper
• Meconium Tenofovir Concentrations and Growth and Bone Outcomes in Prenatally Tenofovir Exposed HIV-Uninfected Children

  2015cites this paper
• The New Face of the Pediatric HIV Epidemic in Western Countries: Demographic Characteristics, Morbidity and Mortality of the Pediatric HIV-infected Population

  2015cites this paper
• Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral Therapy.

  2015cites this paper
• Impaired bone mineral accrual in prepubertal HIV-infected children: a cohort study

  2015cites this paper
• Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients.

  2015cites this paper
• Adverse bone health among children and adolescents growing up with HIV

  2015influential citation
• Getting to 90-90-90 in paediatric HIV: What is needed?

  2015cites this paper
• Achieving 90–90–90 in paediatric HIV: adolescence as the touchstone for transition success

  2015cites this paper
• Perinatally infected adolescents living with human immunodeficiency virus (perinatally human immunodeficiency virus).

  2015cites this paper
• Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy.

  2015cites this paper
• Long-term outcomes of children treated for HIV-infection

  2015cites this paper
• Metabolic and Renal Adverse Effects of Antiretroviral Therapy in HIV-infected Children and Adolescents

  2015cites this paper
• Bone Alterations Associated with HIV

  2014cites this paper
• Bone health in HIV-infected children, adolescents and young adults: a systematic review.

  2014influential citation
• Endocrinopathies in children infected with human immunodeficiency virus.

  2014cites this paper
• Bone health in children and adolescents with perinatal HIV infection

  2013cites this paper
• The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents

  2013cites this paper
• Metabolic complications and treatment of perinatally HIV-infected children and adolescents

  2013cites this paper
• Perinatally HIV‐Infected Adolescents

  2013cites this paper
• Management of HIV Infection

  2012cites this paper